Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)
NCT04469465· Phase 3· Alexion Pharmaceuticals, Inc.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error